Search Results 211-220 of 19172 for prostate cancer

  1. Living With Cancer: Elevated prostate-specific antigen after partial prostate removal - Mayo Clinic News Network

    However, cancer is just one of several possible causes of increased prostate-specific antigen levels. After any procedure for an enlarged prostate, a number of ...

  2. Prostate Exam — A Good First Step when PSA Levels Increase - Mayo Clinic News Network

    Prostate cancer cells make excessive amounts of this protein, so an elevated or increasing PSA level is a possible sign of prostate cancer. That said, the ...

  3. A Study to Evaluate Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer - Mayo Clinic

    ... prostate cancer. Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens ...

  4. Orchestrating Care — and Robotic Surgery — for Prostate Cancer - Mayo Clinic News Network

    Internationally known orchestra conductor Alvaro Gomez is originally from Chile but now lives in Florida and when faced with a diagnosis of prostate cancer, ...

  5. A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies (ARASTEP) - Mayo Clinic

    A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate ...

  6. Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects - Mayo Clinic

    This is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate cancer (mCRPC).

  7. Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study - Mayo Clinic

    Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study. Print details.

  8. Mayo Clinic Radio: Prostate cancer decisions / wrist injuries / rhabdomyolysis

    Prostate cancer is one of the most common types of cancer in men. Usually prostate cancer grows slowly and initially remains confined to the prostate gland ...

  9. Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery - Mayo Clinic

    ... prostate cancer that has been removed by surgery. Androgen can cause the growth of prostate cells. Antihormone therapy may lessen the amount of androgen ...

  10. Overview - Proteases in Cancer Laboratory - Mayo Clinic Research

    These interactions can play a role in the development of cancer, including breast cancer, prostate cancer, pancreatic cancer, lung cancer and ovarian cancer.